Global Reporting Initiative (GRI) G3.1 Allergan Index

More documents

Recommendations

Info

negative impacts on local communities.SO10. Prevention and mitigation measures implementedin operations with significant potential or actualnegative impacts on local communities.Product StewardshipManagement ApproachPR1. Life cycle stages in which health and safetyimpacts of products and services are assessed forimprovement, and percentage of significant productsand service categories subject to such procedures.PR2. Total number of incidents of non-compliance withregulations and voluntary codes concerning health andsafety impacts of products and services during their lifecycle, by type of outcomes.PR3. Type of product and service information requiredby procedures, and percentage of products and servicessubject to such information requirements.PR4. Total number of incidents of non-compliance withregulatory and voluntary codes concerning product andservice information and labeling, by types of outcomes.PR5. Practices related to customer satisfaction,including results of surveys measuring customersatisfaction.PR6. Programs for adherence to laws, standards, andvoluntary codes related to marketing communications,including advertising, promotion, and sponsorship.Corporate ResponsibilitiesCareersCorporate GovernanceFinancial ReportsSustainability Performance ReportAllergan OverviewCorporate ResponsibilitiesCareersCorporate GovernanceFinancial ReportsSustainability Performance ReportAllergan InvestorsEHSAllergan FoundationComplianceCareersResearch and DevelopmentProduct Safety and Animal TestingAllergan OverviewCorporate ResponsibilitiesCareersCorporate GovernanceFinancial ReportsAllergan OverviewCorporate ResponsibilitiesCareersCorporate GovernanceFinancial ReportsAllergan OverviewCorporate ResponsibilitiesCareersCorporate GovernanceFinancial ReportsAllergan OverviewCorporate ResponsibilitiesCareersCorporate GovernanceFinancial ReportsAllergan OverviewCorporate ResponsibilitiesCareersCorporate GovernanceFinancial ReportsAllergan OverviewCorporate ResponsibilitiesCareersCorporate GovernanceFinancial Reports
PR7. Total number of incidents of non-compliance withregulations and voluntary codes concerning marketingcommunications, including advertising, promotion, andsponsorship by type of outcome.PR8. Total number of substantiated complaintsregarding breaches of customer privacy and loss ofcustomer data.PR9. Monetary value of significant fines for noncompliancewith laws and regulations concerning theprovision and use of products and services.Allergan OverviewCorporate ResponsibilitiesCareersCorporate GovernanceFinancial ReportsAllergan OverviewCorporate ResponsibilitiesCareersCorporate GovernanceFinancial ReportsAllergan OverviewCorporate ResponsibilitiesCareersCorporate GovernanceFinancial ReportsGRI Application Level:Self EvaluationReviewed by Third Party External OrganizationsReviewed by GRINotApplicable√√C C+ B B+ A A+√
Page 1 and 2: Global Reporting Initiative (GRI) G
Page 3 and 4: 4.3 Governance Body and/or Independ
Page 5 and 6: 5. Performance IndicatorsEconomicsM
Page 7 and 8: EN15. Number of ICUN Red List speci
Page 9 and 10: management-employee health and safe
Page 11: esolved through formal grievance me

Global Reporting Initiative (GRI) G3.1 Allergan Index

Create successful ePaper yourself

Delete template?

Save as template?